The medical world is witnessing a significant shift in blood sugar therapy with the introduction of GLP-1 transdermal devices. These systems offer a possibly more comfortable alternative to subcutaneous administrations of GLP-1 receptor agonists, reducing the requirement of daily needle pricks. T